Skip to content
Ejaculation.org

Randomised controlled trial · 2012

A prospective randomized study to compare pelvic floor rehabilitation and dapoxetine for treatment of lifelong premature ejaculation

Pastore AL, Palleschi G, Leto A, Pacini L, Iori F, Leonardo C, Carbone A (2012). A prospective randomized study to compare pelvic floor rehabilitation and dapoxetine for treatment of lifelong premature ejaculation. International Journal of Andrology. doi:10.1111/j.1365-2605.2011.01243.x

Key finding
In a 12-week randomised study of 40 men with lifelong PE, 11 of 19 (57%) in the pelvic floor group gained control (mean latency 126.6 s); in the dapoxetine groups, 5 of 8 (30 mg) and 5 of 7 (60 mg) exceeded 180 s.

Summary

This small randomised study compared pelvic floor muscle rehabilitation with on-demand dapoxetine, a short-acting SSRI (selective serotonin reuptake inhibitor) approved in some countries for PE. Forty men with lifelong premature ejaculation and a baseline intravaginal ejaculatory latency time (IELT) of 1 minute or less were randomised to rehabilitation or to dapoxetine 30 or 60 mg. Treatment lasted 12 weeks in both arms.

At the end, 11 of 19 men (57%) in the rehabilitation group were able to control the ejaculation reflex, with a mean IELT of 126.6 seconds. In the dapoxetine group, 5 of 8 men (62.5%) on 30 mg and 5 of 7 (reported as 72%) on 60 mg had an IELT above 180 seconds, with means of 178.2 and 202.8 seconds. The authors describe pelvic floor rehabilitation as promising and cheaper than on-demand dapoxetine.

Limitations

The groups were very small, and the abstract reports results for 34 men, not 40, without explaining the difference. The outcomes differed between arms ("control of the reflex" versus IELT above 180 seconds), so the numbers are not directly comparable, and there was no statistical comparison between treatments in the abstract. Neither arm was blinded.

What it means for you

Both approaches helped some men with lifelong PE over three months. Medication tended to produce somewhat longer times in this study; exercise avoided drug side effects and ongoing cost. The trial is too small to say which is better, and the two can be combined (see the studies on combination therapy).